Skip to content
Clinical Research Made Simple

Clinical Research Made Simple

Trusted Resource for Clinical Trials, Protocols & Progress

Tag: pharmaceutical quality reporting

FDA Guidance on Quality Metrics Program: Enhancing Pharmaceutical Compliance

Posted on May 9, 2025 digi By digi

FDA Guidance on Quality Metrics Program: Enhancing Pharmaceutical Compliance Comprehensive Overview of the FDA’s Quality Metrics Program and Its Impact on Pharma Compliance The FDA’s Quality Metrics Program is a strategic initiative aimed at encouraging pharmaceutical manufacturers to adopt a data-driven culture of quality. Launched under the purview of the FDA’s Center for Drug Evaluation…

Read More “FDA Guidance on Quality Metrics Program: Enhancing Pharmaceutical Compliance” »

Regulatory Guidelines, U.S. FDA Regulations

Quick Guide

  • Clinical Trial Phases
    • Preclinical Studies
    • Phase 0 (Microdosing Studies)
    • Phase 1 (Safety and Dosage)
    • Phase 2 (Efficacy and Side Effects)
    • Phase 3 (Confirmation and Monitoring)
    • Phase 4 (Post-Marketing Surveillance)
  • Regulatory Guidelines
    • U.S. FDA Regulations
    • CDSCO (India) Guidelines
    • EMA (European Medicines Agency) Guidelines
    • PMDA (Japan) Guidelines
    • MHRA (UK) Guidelines
    • TGA (Australia) Guidelines
    • Health Canada Guidelines
    • WHO Guidelines
    • ICH Guidelines
    • ASEAN Guidelines
  • Clinical Trial Design and Protocol Development
    • Randomized Controlled Trials (RCTs)
    • Adaptive Trial Designs
    • Crossover Trials
    • Parallel Group Designs
    • Factorial Designs
    • Cluster Randomized Trials
    • Single-Arm Trials
    • Open-Label Studies
    • Blinded Studies (Single, Double, Triple)
    • Non-Inferiority and Equivalence Trials
    • Randomization Techniques in Crossover Trials
  • Good Clinical Practice (GCP) and Compliance
    • GCP Training Programs
    • ICH-GCP Compliance
    • GCP Violations and Audit Responses
    • Monitoring Plans
    • Investigator Responsibilities
    • Sponsor Responsibilities
    • Ethics Committee Roles

Menu

Recent Posts

  • Regulatory Requirements for Group Comparisons – Clinical Trial Design and Protocol Development
  • Cardiac Safety in Phase 1: QTc and Intensive ECG Monitoring
  • Endpoint Hierarchy Planning and Sensitivity Analyses in Phase 3 Trials: Ensuring Statistical Validity and Regulatory Confidence
  • Data Mining for Adverse Drug Reactions in Phase 4 Clinical Trials
  • Examples of Parallel Designs in Oncology Trials – Clinical Trial Design and Protocol Development

Copyright © 2025 Clinical Research Made Simple.

Powered by PressBook WordPress theme